Søren Tulstrup

Soren Tulstrup serves as the President & CEO of Hansa Biopharma AB (publ) since 2018 and has held various advisory and board positions, including roles at GLG Institute, Appnovation, and Santhera Pharmaceuticals. Previously, Soren was CEO of Vifor Pharma and held senior executive roles at Shire Pharmaceuticals and Santaris Pharma A/S. With extensive experience at Merck & Co., Inc. and Novartis (Sandoz Pharma), Soren's career spans significant leadership positions in the life sciences sector. Soren Tulstrup holds a Master of Management from Northwestern University - Kellogg School of Management, an International Directors Programme certificate from INSEAD, and advanced degrees in Economics & Business Administration from Copenhagen Business School.